2-(4-(6-(6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino)pyridin-3-yl)piperazin-1-yl)-N-(2-(2-(2-(2-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-ylamino)ethoxy)ethoxy)ethoxy)ethyl)acetamide

ID: ALA4548417

PubChem CID: 138490129

Max Phase: Preclinical

Molecular Formula: C47H57N11O10

Molecular Weight: 936.04

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(CC(=O)NCCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)cn3)nc2n(C2CCCC2)c1=O

Standard InChI:  InChI=1S/C47H57N11O10/c1-29-34-27-51-47(54-42(34)57(31-6-3-4-7-31)45(64)40(29)30(2)59)52-37-12-10-32(26-50-37)56-18-16-55(17-19-56)28-39(61)49-15-21-67-23-25-68-24-22-66-20-14-48-35-9-5-8-33-41(35)46(65)58(44(33)63)36-11-13-38(60)53-43(36)62/h5,8-10,12,26-27,31,36,48H,3-4,6-7,11,13-25,28H2,1-2H3,(H,49,61)(H,53,60,62)(H,50,51,52,54)

Standard InChI Key:  UTSBHEVQCONLCR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 68 75  0  0  0  0  0  0  0  0999 V2000
   27.2499  -15.4896    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.5983  -15.4935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0181  -16.2099    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.8420  -16.2041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0098  -14.7762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8346  -14.7739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2430  -14.0598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.8281  -13.3473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0003  -13.3536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5954  -14.0684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0691  -14.0539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5568  -14.7194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3404  -14.4614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3372  -13.6364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5515  -13.3847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2589  -16.9160    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.2365  -12.6305    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.5821  -12.6424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9889  -11.9247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7571  -12.6490    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7704  -14.0743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0838  -16.9111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4972  -17.6233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3214  -17.6187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7304  -16.9012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3092  -16.1869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4863  -16.1950    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.5526  -16.8925    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.9691  -17.6057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7905  -17.6017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2016  -16.8860    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.7850  -16.1728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9574  -16.1752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0266  -16.8831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4366  -16.1671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2615  -16.1642    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0215  -15.4542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.6715  -15.4483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4965  -15.4454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9065  -14.7294    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.7315  -14.7265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1414  -14.0105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9664  -14.0076    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.3764  -13.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2014  -13.2887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6164  -14.0017    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.4414  -13.9988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8513  -13.2828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6763  -13.2799    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.0914  -13.9929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6796  -14.7077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0939  -15.4201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.9198  -15.4177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.9128  -13.9872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3302  -14.6962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1335  -14.5184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.2126  -13.6993    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.4582  -13.3711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.9208  -13.2823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.6385  -13.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.3474  -13.2759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.3446  -12.4506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.6268  -12.0420    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.9118  -12.4587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.2799  -12.5657    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.1943  -12.0515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   47.0572  -12.0348    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.7511  -15.0653    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  2  0
  5  2  2  0
  2  3  1  0
  3  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
  7 11  1  0
  4 16  1  0
  8 17  2  0
  9 18  1  0
 18 19  1  0
 18 20  2  0
 10 21  1  0
 16 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 25 28  1  0
 31 34  1  0
 34 35  1  0
 35 36  1  0
 35 37  2  0
 36 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 44 45  1  0
 45 46  1  0
 46 47  1  0
 47 48  1  0
 48 49  1  0
 49 50  1  0
 50 51  2  0
 51 52  1  0
 52 53  2  0
 53 55  1  0
 54 50  1  0
 54 55  2  0
 55 56  1  0
 56 57  1  0
 57 58  1  0
 58 54  1  0
 59 60  1  0
 59 64  1  0
 60 61  1  0
 61 62  1  0
 62 63  1  0
 63 64  1  0
 57 59  1  0
 58 65  2  0
 64 66  2  0
 62 67  2  0
 56 68  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA4548417

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 936.04

Molecular Weight (Monoisotopic): 935.4290

AlogP: 2.36

#Rotatable Bonds: 21

Polar Surface Area: 248.62

Molecular Species: NEUTRAL

HBA: 18

HBD: 4

#RO5 Violations: 2

HBA (Lipinski): 21

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 11.15

CX Basic pKa: 6.10

CX LogP: 1.87

CX LogD: 1.85

Aromatic Rings: 4

Heavy Atoms: 68

QED Weighted: 0.05

Np Likeness Score: -1.10

References

1. Su S, Yang Z, Gao H, Yang H, Zhu S, An Z, Wang J, Li Q, Chandarlapaty S, Deng H, Wu W, Rao Y..  (2019)  Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders.,  62  (16): [PMID:31330105] [10.1021/acs.jmedchem.9b00871]

2. Anderson NA, Cryan J, Ahmed A, Dai H, McGonagle GA, Rozier C, Benowitz AB..  (2020)  Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs.,  30  (9): [PMID:32184044] [10.1016/j.bmcl.2020.127106]

3. Bricelj A, Dora Ng YL, Ferber D, Kuchta R, Müller S, Monschke M, Wagner KG, Krönke J, Sosič I, Gütschow M, Steinebach C..  (2021)  Influence of Linker Attachment Points on the Stability and Neosubstrate Degradation of Cereblon Ligands.,  12  (11.0): [PMID:34795861] [10.1021/acsmedchemlett.1c00368]

4. Fry, David W DW and 10 more authors.  2004-11  Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts.  [PMID:15542782]

5. Squires, Matthew S MS and 7 more authors.  2009-02  Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines.  [PMID:19174555]

6. Cirstea, D D and 15 more authors.  2013-12  Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs.  [PMID:23807770]

7. Gelbert, Lawrence M LM and 16 more authors.  2014-10  Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine.  [PMID:24919854]

8. Paiva, Cody C and 8 more authors.  2015  Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells.  [PMID:26606677]

9. Bisi, John E JE, Sorrentino, Jessica A JA, Roberts, Patrick J PJ, Tavares, Francis X FX and Strum, Jay C JC.  2016-05  Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression.  [PMID:26826116]

10. Wang, Yan Y and 10 more authors.  2018-03-01  Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity relationships.  [PMID:29429832]

11. Zhi, Yanle Y and 9 more authors.  2018-07-15  Discovery of the selective and efficacious inhibitors of FLT3 mutations.  [PMID:29894944]

Source

Source(1):

• Scientific Literature